Ftse Mib
34.180,84
-0,34%
DAX
18.040,23
-0,50%
S&P 500
5.116,17
0,32%
NASDAQ Composite
15.983,08
0,35%
Bitcoin
61.818,71
-3,16%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Gilead Sciences Inc (GILD) Gilead Sciences Inc (GILD) Notizie

Gilead Sciences Inc

GILD
65,94
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 11:28:48
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
26/4/202414:00BWFDA Approves Biktarvy® Label Update With Data for Pregnant..
26/4/202413:47IHMARKETNEWSExxon Mobil Net Profit Drops 28% to $8.22 Billion, Atlassian..
25/4/202422:02BWGilead Sciences Announces First Quarter 2024 Financial..
25/4/202413:53IHMARKETNEWSU.S. Futures Drop in Pre-Market Trading as Tech Stocks..
08/4/202422:05BWGilead Sciences to Release First Quarter 2024 Financial..
28/3/202413:30BWFDA Expands Indication for Gilead's Vemlidy (Tenofovir..
28/3/202412:00GLOBEGilead and Xilio Announce Exclusive License Agreement for..
22/3/202414:18BWGilead Sciences Announces Completion of Acquisition of..
19/3/202400:29BWCenter for Disease Analysis Foundation Announces First Round..
11/3/202413:34EDGAR2Form SC TO-T/A - Tender offer statement by Third Party:..
11/3/202413:24BWGilead Sciences Announces Expiration of Hart-Scott-Rodino..
06/3/202422:30BWBiktarvy® Demonstrates High Rates of Viral Suppression in..
06/3/202416:25BWGilead and Merck Announce Phase 2 Data Showing an..
06/3/202414:00BWGilead and Merus Announce Collaboration to Discover Novel..
05/3/202422:35BWNew Real-World Data Further Support the Use of Veklury®..
05/3/202422:30BWGilead’s Innovative HIV Treatment Research Pipeline Aims to..
01/3/202400:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202422:49EDGAR2Form 144 - Report of proposed sale of securities
28/2/202422:38EDGAR2Form 144 - Report of proposed sale of securities
27/2/202416:00BWGilead Announces Funding Initiative to Support HIV..
26/2/202422:05BWU.S. FDA Approves Expanded Indication for Gilead’s Biktarvy®..
26/2/202414:30BWGilead to Present Late-Breaking Data and Real-World Evidence..
23/2/202412:09EDGAR2Form SC TO-T - Tender offer statement by Third Party
20/2/202422:31EDGAR2Form SC 13G - Statement of acquisition of beneficial..
20/2/202422:05BWGilead Sciences to Present at Upcoming Investor Conferences
14/2/202423:08EDGAR2Form SC TO-C - Written communication relating to an issuer..
13/2/202423:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/2/202422:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202422:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202422:14EDGAR2Form SC TO-C - Written communication relating to an issuer..
12/2/202414:39EDGAR2Form SC TO-C - Written communication relating to an issuer..
12/2/202414:37EDGAR2Form 8-K - Current report
10/2/202400:21EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
09/2/202417:00BWGilead Named One of America’s Most JUST Companies by JUST..
07/2/202423:35EDGAR2Form 3 - Initial statement of beneficial ownership of..
07/2/202411:49IHMARKETNEWSMoody’s Downgrades NYCB to Junk Status, Ford Declares..
07/2/202400:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202422:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/2/202422:05BWGilead Sciences Announces 2.7 Percent Increase in First..
06/2/202422:04EDGAR2Form 8-K - Current report
06/2/202422:02BWGilead Sciences Announces Fourth Quarter and Full Year 2023..
06/2/202412:27IHMARKETNEWSUS Index Futures Mixed, Oil Prices Edge Higher
02/2/202422:20EDGAR2Form 8-K - Current report
02/2/202420:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202420:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202420:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202420:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202419:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:31BWTed Love, MD, Joins Gilead Sciences’ Board of Directors
31/1/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: Min: Max:
Chiusura: 65,94

La tua Cronologia

NASDAQ
GILD
Gilead Sciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network